Patients Are Debating The Latest Mychart Kettering Health Network Update
参考文献：A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction.
Kettering Health | Be Your Best
